0001874298-26-000004.txt : 20260723 0001874298-26-000004.hdr.sgml : 20260723 20260723151017 ACCESSION NUMBER: 0001874298-26-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260723 DATE AS OF CHANGE: 20260723 EFFECTIVENESS DATE: 20260723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allotera Therapeutics, Inc. CENTRAL INDEX KEY: 0001874298 ORGANIZATION NAME: EIN: 830731792 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-556954 FILM NUMBER: 261196735 BUSINESS ADDRESS: STREET 1: 4260 FOREST PARK AVE., SUITE 100 CITY: ST. LOUIS STATE: MO ZIP: 63110 BUSINESS PHONE: 314-501-1968 MAIL ADDRESS: STREET 1: 4260 FOREST PARK AVE., SUITE 100 CITY: ST. LOUIS STATE: MO ZIP: 63110 FORMER COMPANY: FORMER CONFORMED NAME: AlloTera Therapeutics, Inc. DATE OF NAME CHANGE: 20260716 FORMER COMPANY: FORMER CONFORMED NAME: Wugen, Inc. DATE OF NAME CHANGE: 20210721 D/A 1 primary_doc.xml X0708 D/A LIVE 0001874298 Allotera Therapeutics, Inc. 4260 FOREST PARK AVE., SUITE 100 ST. LOUIS MO MISSOURI 63110 314-501-1968 DELAWARE AlloTera Therapeutics, Inc. Wugen, Inc. Corporation true Niall O'Donnell c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Director Bali Muralidhar c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Director Peter Kiener c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Director Drew Dennison c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Director Kevin Li c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Director Bosun Hau c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Director Matthew Cooper c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Executive Officer Ayman Kabakibi c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Executive Officer Natalie Mount c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Director Kumar Srinivasan c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Executive Officer Director Cherry Thomas c/o Allotera Therapeutics, Inc. 4260 Forest Park Ave., Suite 100 St. Louis MO MISSOURI 63108 Executive Officer Other Health Care Decline to Disclose 06b true 0001874298-25-000004 2025-08-22 false true true true false 0 163043971 123313778 39730193 Includes amounts receivable upon exercise of warrants to purchase shares of Series C Preferred Stock; such warrants have not yet been exercised. false 20 0 0 0 false Allotera Therapeutics, Inc. /s/ Kumar Srinivasan Kumar Srinivasan President and Chief Executive Officer 2026-07-23